OBI PHARMA
LIVE

Serial Number

86014025

Owner

OBI PHARMA, INC.

Attorney

Michael T. Smith

Filing Date

Jul 18, 2013

Add to watchlist:

No watchlists yet
View on USPTO

OBI PHARMA Trademark

Serial Number: 86014025 • Registration: 4737391

OBI PHARMA is a trademark filed by OBI PHARMA, INC. on July 18, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

OBI PHARMA, INC. (13 trademarks)

Nankang Software Park
Taipei 11503 , TW

Entity Type: 03

Trademark Details

Filing Date

July 18, 2013

Registration Date

May 19, 2015

Published for Opposition

March 3, 2015

Goods & Services

[ Antibiotic preparations; Antibiotics; ] Anti-cancer preparations; [ Anti-infectives; Anti-inflammatories; ] Biological preparations for the treatment of cancer; Chemical reagents for medical or veterinary purposes; [ Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for medical purposes; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; ] Gastro-intestinal treatment preparations; [ In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis of body fluids; ] Medicinal preparations for the treatment of infectious diseases and for using in oncology; [ Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ] Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; [ Reagents and media for medical and veterinary diagnostic purposes; ] Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Vaccines

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 21, 2026 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 21, 2026 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 21, 2026 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 19, 2026 APRE
TEAS SECTION 8 & 9 RECEIVED
Nov 19, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 19, 2024 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2024 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Mar 27, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 27, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 27, 2024 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Apr 2, 2022 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Apr 2, 2022 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 2, 2022 APRE
TEAS SECTION 8 RECEIVED
Sep 24, 2021 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 19, 2020 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 2, 2019 TCCA
REGISTERED-PRINCIPAL REGISTER
May 19, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2015 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 26, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 15, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 15, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 16, 2014 GNRN
NON-FINAL ACTION E-MAILED
Jul 16, 2014 GNRT
NON-FINAL ACTION WRITTEN
Jul 16, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2014 CRFA
ASSIGNED TO LIE
Jul 4, 2014 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 25, 2014 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 21, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 21, 2014 GNSL
SUSPENSION LETTER WRITTEN
Mar 21, 2014 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 21, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 6, 2013 GNRN
NON-FINAL ACTION E-MAILED
Nov 6, 2013 GNRT
NON-FINAL ACTION WRITTEN
Nov 6, 2013 CNRT
ASSIGNED TO EXAMINER
Oct 31, 2013 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Aug 7, 2013 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 7, 2013 PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 6, 2013 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 25, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 24, 2013 NWOS
NEW APPLICATION ENTERED
Jul 22, 2013 NWAP